Science Explorer Interactive view Map
Company · Siena · Italy

Philogen (Italy)

philogen.comROR OpenAlex
Research works
43
▲ 126% vs 2013–17
Citations
1.1k
25.9 per fractional work
Top-10% rate
27.6%
record average 16.5%
Open access
51%
world 28%

Not ranked overall: Philogen (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.78× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 5.55× its world share, 1 worksImmunology and Micro…Neuroscience: 1.01× its world share, 0 worksNeuroscienceChemistry: 3.15× its world share, 1 worksChemistryComputer Science: 0.18× its world share, 0 worksComputer ScienceEngineering: 0.19× its world share, 0 worksEngineeringEnvironmental Science: 0.06× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.41× its world share, 0 worksMaterials ScienceMedicine: 3.21× its world share, 11 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.5×. Every wedge is a field page.

Which keywords describe research at Philogen (Italy)?

By fractional works in all years, weighted toward what it does more of than the world: PET Imaging, Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Immunotherapy, Antibody Engineering, Fc Receptors and Angiogenesis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. PET Imaging8▲ 80×3 topics
  2. Glycosylation7▲ 75×3 topics
  3. Monoclonal Antibodies7▲ 106×3 topics
  4. Therapeutic Antibodies6▲ 115×2 topics
  5. Immunotherapy6▲ 22×10 topics
  6. Angiogenesis6▲ 33×6 topics
  7. Antibody Engineering6▲ 138×1 topic
  8. Fc Receptors6▲ 138×1 topic
  9. Cancer4▲ 7.4×8 topics
  10. Cancer Immunotherapy4▲ 75×2 topics
  11. Cancer Therapy4▲ 16×7 topics
  12. Targeted Therapy4▲ 46×4 topics
  13. Tumor Microenvironment4▲ 27×3 topics
  14. Cancer Treatment4▲ 34×2 topics
  15. Dosimetry4▲ 94×2 topics
  16. Radioimmunotherapy4▲ 210×1 topic
  17. Radiopharmaceuticals4▲ 210×1 topic
  18. Fibroblast Activation Protein3▲ 148×1 topic
  19. Immunosuppression3▲ 65×1 topic
  20. Tumor Regression3▲ 87×2 topics
  21. Inflammation3▲ 3.1×10 topics
  22. Lymphoma3▲ 48×2 topics
  23. CAR T Cells2▲ 129×1 topic
  24. Chimeric Antigen Receptor2▲ 129×1 topic
  25. Drug Discovery2▲ 14×3 topics
  26. Antigen Presentation2▲ 52×2 topics
  27. Immunity2▲ 16×3 topics
  28. Innate Immunity2▲ 15×3 topics
  29. Dendritic Cells2▲ 44×2 topics
  30. Tumor Antigen2▲ 59×1 topic
  31. Vaccine Adjuvants2▲ 59×1 topic
  32. Extracellular Matrix2▲ 18×2 topics
  33. Tumor Targeting2▲ 31×3 topics
  34. Cell Adhesion2▲ 46×1 topic
  35. Integrins2▲ 68×1 topic
  36. Foldamers2▲ 46×1 topic
  37. Peptide Synthesis2▲ 46×1 topic
  38. Gene Therapy1▲ 11×3 topics
  39. Imaging1▲ 7.8×2 topics
  40. Glycans1▲ 30×1 topic

Which research topics does Philogen (Italy) publish most on?

By volume in 2022–2025: Peptidase Inhibition and Analysis, Radiopharmaceutical Chemistry and Applications, Monoclonal and Polyclonal Antibodies Research and CAR-T cell therapy research.

Peptidase Inhibition and…3Peptidase Inhibition and Analysis: 3 fractional worksRadiopharmaceutical Chemistry and Applications: 2 fractional worksMonoclonal and Polyclonal Antibodies Research: 2 fractional worksCAR-T cell therapy research: 1 fractional worksChemical Synthesis and Analysis: 1 fractional worksGlioma Diagnosis and Tre…1Glioma Diagnosis and Treatment: 1 fractional worksMedical Imaging Techniques and Applications: 0 fractional worksNanoplatforms for cancer theranostics: 0 fractional worksCancer Research and Treatments: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional works
OncologyRadiology, Nuclear Medicine and ImagingMolecular BiologyGenetics3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Peptidase Inhibition and Analysis Oncology 3 works
  2. 2 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 2 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  4. 4 CAR-T cell therapy research Oncology 1 works
  5. 5 Chemical Synthesis and Analysis Molecular Biology 1 works
  6. 6 Glioma Diagnosis and Treatment Genetics 1 works
  7. 7 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
  8. 8 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  9. 9 Cancer Research and Treatments Biotechnology 0 works
  10. 10 Immunotherapy and Immune Responses Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.9%not open49.1%

World: 28% of research is openly available.

with international co-authors79.1%domestic only20.9%

World: 19% is written across borders.

How has Philogen (Italy)'s research output changed?

Output in 2018–2022 was 126% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Siena

All research institutions in Siena

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.